- Home
- ZYXI vs CBUS Comparison
ZYXI vs CBUS Comparison
Compare ZYXI & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- CBUS
- Stock Information
- Founded
- ZYXI 1996
- CBUS 2010
- Country
- ZYXI United States
- CBUS United States
- Employees
- ZYXI N/A
- CBUS N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CBUS Agricultural Chemicals
- Sector
- ZYXI Health Care
- CBUS Industrials
- Exchange
- ZYXI Nasdaq
- CBUS Nasdaq
- Market Cap
- ZYXI 66.5M
- CBUS 65.3M
- IPO Year
- ZYXI N/A
- CBUS 2017
- Fundamental
- Price
- ZYXI $2.07
- CBUS $2.15
- Analyst Decision
- ZYXI Buy
- CBUS Strong Buy
- Analyst Count
- ZYXI 3
- CBUS 3
- Target Price
- ZYXI $6.00
- CBUS $22.17
- AVG Volume (30 Days)
- ZYXI 229.1K
- CBUS 130.0K
- Earning Date
- ZYXI 04-29-2025
- CBUS 05-08-2025
- Dividend Yield
- ZYXI N/A
- CBUS N/A
- EPS Growth
- ZYXI N/A
- CBUS N/A
- EPS
- ZYXI N/A
- CBUS N/A
- Revenue
- ZYXI $172,401,000.00
- CBUS $4,751,000.00
- Revenue This Year
- ZYXI N/A
- CBUS $105.58
- Revenue Next Year
- ZYXI $23.16
- CBUS $194.76
- P/E Ratio
- ZYXI N/A
- CBUS N/A
- Revenue Growth
- ZYXI N/A
- CBUS 104.78
- 52 Week Low
- ZYXI $1.66
- CBUS $1.40
- 52 Week High
- ZYXI $11.15
- CBUS $19.56
- Technical
- Relative Strength Index (RSI)
- ZYXI 40.51
- CBUS 53.10
- Support Level
- ZYXI $1.95
- CBUS $1.96
- Resistance Level
- ZYXI $2.19
- CBUS $2.58
- Average True Range (ATR)
- ZYXI 0.21
- CBUS 0.25
- MACD
- ZYXI 0.08
- CBUS 0.04
- Stochastic Oscillator
- ZYXI 45.05
- CBUS 42.76
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.